Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Settles Saint Louis U. Lawsuit Over Primer Extension Patent

NEW YORK, Aug. 7-Orchid BioSciences said today that it had settled its patent lawsuit with Saint Louis University over SNP primer extension technology.


That litigation involved a dispute over the rights to SNP scoring technology developed by Saint Louis University molecular biologist S. Paul Bajaj. Orchid filed suit against the university in 2000, seeking a court ruling that its technology did not violate the Saint Louis U. patent.


Orchid now has full ownership of the patent, which gives it control of two nonexclusive royalty-bearing licenses. Financial details of the settlement were not revealed.


Orchid also said today that it had placed five of its new SNPstream UHT genotyping systems since late 2001, when the system was introduced. Customers include the agricultural genomics firm MMI Genomics and McGill University.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.